Obinutuzumab (anti-CD20)
Product Specifications
CAS Number
949142-50-1
Synonyms
Gazyva, GA101, Gazyvaro, Afutuzumab
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Obinutuzumab (anti-CD20) (Gazyva, GA101, Gazyvaro, Afutuzumab) is a novel, type II, glycoengineered, humanized anti-CD20 monoclonal antibody that has been developed for lymphocytic leukemia and lymphoma of B-cell origin. MW : 146.1 kD.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2087107 1.0 µg DNA
SAMD7 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details